 | Up a level |
2020
Robert, Caroline 
ORCID: 0000-0002-9493-0238, Long, Georgina V., Brady, Benjamin, Dutriaux, Caroline, Di Giacomo, Anna Maria, Mortier, Laurent, Rutkowski, Piotr, Hassel, Jessica C., McNeil, Catriona M., Kalinka, Ewa Anna, Lebbe, Celeste, Charles, Julie, Hernberg, Micaela M., Savage, Kerry J., Chiarion-Sileni, Vanna, Mihalcioiu, Catalin, Mauch, Cornelia, Arance, Ana, Cognetti, Francesco, Ny, Lars, Schmidt, Henrik, Schadendorf, Dirk, Gogas, Helen, Zoco, Jesus, Re, Sandra, Ascierto, Paolo A. and Atkinson, Victoria
(2020).
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma.
J. Clin. Oncol., 38 (33).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2019
Ascierto, Paolo A., Long, Georgina V., Robert, Caroline ORCID: 0000-0002-9493-0238, Brady, Benjamin, Dutriaux, Caroline, Di Giacomo, Anna Maria, Mortier, Laurent, Hassel, Jessica C., Rutkowski, Piotr ORCID: 0000-0002-8920-5429, McNeil, Catriona, Kalinka-Warzocha, Ewa, Savage, Kerry J., Hernberg, Micaela M., Lebbe, Celeste, Charles, Julie, Mihalcioiu, Catalin, Chiarion-Sileni, Vanna, Mauch, Cornelia, Cognetti, Francesco, Ny, Lars ORCID: 0000-0003-3864-5958, Arance, Ana, Svane, Inge Marie ORCID: 0000-0002-9451-6037, Schadendorf, Dirk, Gogas, Helen, Saci, Abdel, Jiang, Joel, Rizzo, Jasmine and Atkinson, Victoria
(2019).
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy Three-Year Follow-up of a Randomized Phase 3 Trial.
JAMA Oncol., 5 (2).
S. 187 - 195.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 2374-2445